药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688046 药康生物

已收盘 12-20 15:00:00

{"stockData":{"symbol":"688046","market":"SH","secType":"STK","nameCN":"药康生物","latestPrice":13.9,"timestamp":1734678000000,"preClose":13.93,"halted":0,"volume":1404877,"delay":0,"floatShares":204000000,"shares":409999999,"eps":0.3401,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.03,"latestTime":"12-20 15:00:00","open":13.92,"high":14.14,"low":13.8,"amount":19640400,"amplitude":0.0244,"askPrice":13.9,"askSize":29,"bidPrice":13.89,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.3401,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":13.93,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":15.32,"lowLimit":12.54,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":410000000,"pbRate":2.68,"roa":"--","roe":"4.61%","epsLYR":0.39,"committee":-0.360465,"marketValue":5699000000,"floatMarketCap":2835000000,"peRate":40.870333,"changeRate":-0.0022,"turnoverRate":0.0069,"status":1,"afterMarket":{"amount":0,"volume":0,"close":13.9,"buyVolume":0,"sellVolume":0,"time":1734680038975,"indexStatus":"已收盘 12-20 15:30:00","preClose":13.93}},"requestUrl":"/m/hq/s/688046","defaultTab":"news","newsList":[{"id":"2492541448","title":"药康生物收盘下跌0.22%，滚动市盈率40.88倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2492541448","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492541448?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:41","pubTimestamp":1734698471,"startTime":"0","endTime":"0","summary":"12月20日，药康生物今日收盘13.9元，下跌0.22%，滚动市盈率PE达到40.88倍。从行业市盈率排名来看，公司所处的生物制品行业市盈率平均35.80倍，行业中值36.44倍，药康生物排名第55位。截至2024年三季报，共有16家机构持仓药康生物，其中基金10家、其他6家，合计持股数9709.69万股，持股市值14.36亿元。最新一期业绩显示，2024年三季报，公司实现营业收入5.10亿元，同比12.13%；净利润9821.44万元，同比-16.57%，销售毛利率63.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220204411a1fde03d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220204411a1fde03d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2492100239","title":"药康生物（688046）12月17日主力资金净卖出95.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492100239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492100239?lang=zh_cn&edition=full","pubTime":"2024-12-18 08:17","pubTimestamp":1734481060,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月17日收盘，药康生物报收于14.18元，上涨0.57%，换手率1.77%，成交量3.61万手，成交额5092.41万元。近5日资金流向一览见下表：药康生物融资融券信息显示，融资方面，当日融资买入292.66万元，融资偿还265.13万元，融资净买入27.53万元，连续3日净买入累计557.75万元。药康生物主营业务：实验动物模型的研发创制、生产销售及相关技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121800008428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2490586177","title":"药康生物12月11日主力资金流出372万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2490586177","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490586177?lang=zh_cn&edition=full","pubTime":"2024-12-11 15:20","pubTimestamp":1733901652,"startTime":"0","endTime":"0","summary":"12月11日，药康生物股价收平报14.55元，成交金额4659万元，换手率1.57%，振幅2.06%，量比0.79。药康生物今日主力资金净流出372万元，连续3日净流出，上一交易日主力净流出1029万元，今日环比减少63.85%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为61.11%，平均跌幅为2.00%。该股近5个交易日上涨2.83%，主力资金累计净流出3200万元；近20日主力资金累计净流出5812万元，其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211154115ab6ee57e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211154115ab6ee57e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长，机构：医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上，据医保局日前披露，2024年1-10月医保统筹基金收入23065.07亿元，同比增长8.9%；2024年1-10月统筹支出19165.88亿元，同比增长8.9%。对此，国泰君安表示，1-10月医保统筹基金运行平稳，收入稳健增长，支出增速逐月收窄。国金证券表示，由于多方面因素，医药板块景气度在2021年后经历了长时间的下行。2024年11月7日，国家医保局召开了座谈会，强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688139","688356","688575","688266","688670","600535","688617","603301","BK0185","600252","688105","600771","605199","600422","688247","603259","688506","600511","603658","688176","600721","600161","688276","600572","600200","603439","603707","688029","603309","688137","688046","600436","688488","603127","688091","688298","600055","688198","603882","688050","603538","688271","603896","600998","688212","600488","600739","600529","BK0028","688520","BK0188","688177","600211","688336","600085","688581","600129","688062","BK0070","600062","688626","688443","BK0012","605177","600867","688235","600079","603939","688180","688192","688166","688301","600080","688278","600763","688193","688656","688161","603233","600566","603567","600521","603392","688321","688687","688117","603456","688202","688315","600196","603590","688382","688067","159938","688085","688373","603108","688767","600285","600380","601607","688114","688351","688578","688389","BK0096","688566","688189","600976","688428","600056","688690","BK0239","600276","688222","603367","688076","600329","600420","600332","600851","688331","603087","688073","600351","688658","603858","688163","688221"],"gpt_icon":0},{"id":"2486281692","title":"药康生物涨5.15% 国家医保局出新规","url":"https://stock-news.laohu8.com/highlight/detail?id=2486281692","media":"智选洞察","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486281692?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:00","pubTimestamp":1732690803,"startTime":"0","endTime":"0","summary":"消息解读11 月 26 日，国家医保局发布《超声检查类医疗服务价格项目立项指南(试行)》。国家医保局正在推动一批量大价高的检查检验项目合理下调价格，目的是进一步减轻患者的就医负担，并促进各省份间检查检验价格的相对均衡。最新财报显示，今年三季报，药康生物实现营业收入5.10亿元，同比增长12.13%，净利润为9,821.44万元，同比减少16.57%，基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127150131abe287f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127150131abe287f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2485281666","title":"药康生物跌5% 6券商看好","url":"https://stock-news.laohu8.com/highlight/detail?id=2485281666","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485281666?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:51","pubTimestamp":1732258318,"startTime":"0","endTime":"0","summary":"11月22日，药康生物股价大幅下跌，截至14点51分，药康生物下跌5.03%，报13.03元/股，成交4978万元，换手率1.84%。资金动向截止发稿，药康生物获得主力净流入332万元，其中超大单流入205万元，大单流入127万元。主营业务及业绩药康生物公司主营业务为实验动物小鼠模型的研发、生产、销售及相关技术服务。最新财报显示，今年三季报，药康生物实现营业收入5.10亿元，同比增长12.13%，净利润为9,821.44万元，同比减少16.57%，基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150106a24d3716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122150106a24d3716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2484614212","title":"药康生物11月18日主力资金流出53万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484614212","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484614212?lang=zh_cn&edition=full","pubTime":"2024-11-18 15:19","pubTimestamp":1731914395,"startTime":"0","endTime":"0","summary":"11月18日, 药康生物股价跌3.87%，报收12.90元，成交金额6091万元，换手率2.27%，振幅5.59%，量比0.82。药康生物今日主力资金净流出53万元，连续7日净流出，上一交易日主力净流出403万元，今日环比减少86.85%。该股近5个交易日下跌13.54%，主力资金累计净流出1964万元；近20日主力资金累计净流出6897万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118153537a2422b57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118153537a2422b57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2483634846","title":"药康生物11月14日遭主力抛售882万元 环比增加361.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483634846","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483634846?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:20","pubTimestamp":1731568836,"startTime":"0","endTime":"0","summary":"11月14日, 药康生物股价跌4.53%，报收13.70元，成交金额7836万元，换手率2.75%，振幅4.81%，量比0.88。药康生物今日主力资金净流出882万元，连续5日净流出，上一交易日主力净流出191万元，今日环比增加361.78%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为37.50%，平均跌幅为4.70%。该股近5个交易日下跌4.06%，主力资金累计净流出3549万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出5927万元，其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114154118a2369501&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114154118a2369501&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2482726053","title":"药康生物11月12日主力资金流出437万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2482726053","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482726053?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:21","pubTimestamp":1731396074,"startTime":"0","endTime":"0","summary":"11月12日, 药康生物股价跌1.01%，报收14.77元，成交金额1.08亿元，换手率3.55%，振幅5.09%，量比1.06。药康生物今日主力资金净流出437万元，连续3日净流出，上一交易日主力净流出705万元，今日环比减少38.01%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为58.82%，平均跌幅为1.74%。该股近5个交易日上涨5.50%，主力资金累计净流出3411万元；近20日主力资金累计净流出5091万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112154806a22f8620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112154806a22f8620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2481924898","title":"药康生物：拟回购2000万元-4000万元股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2481924898","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481924898?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:54","pubTimestamp":1730969692,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2481213945","title":"国元证券：给予药康生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481213945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481213945?lang=zh_cn&edition=full","pubTime":"2024-11-07 14:01","pubTimestamp":1730959275,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛,朱仕平近期对药康生物进行研究并发布了研究报告《2024年三季度报告点评：扩张期成本增加及政府补助减少使得利润短期承压》，本报告对药康生物给出买入评级，当前股价为14.26元。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级3家，增持评级4家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700019208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","000728"],"gpt_icon":0},{"id":"2481948040","title":"药康生物2024年三季度报告点评：扩张期成本增加及政府补助减少使得利润短期承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2481948040","media":"国元证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481948040?lang=zh_cn&edition=full","pubTime":"2024-11-07 00:00","pubTimestamp":1730908800,"startTime":"0","endTime":"0","summary":"事件药康生物于近日发布2024 年三季度报告：2024 年前三季度公司实现收入5.1 亿元，实现归母净利润9821.4 万元、扣非归母净利润7181.0 万元。利润下降主要系公司目前仍处扩张期，生产规模扩大成本增加，持续加大海外市场开发力度销售费用上涨等原因，使公司利润短期承压；同时本年度取得政府补助金额较上年同期减少。维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110713412295bde2fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110713412295bde2fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2481640365","title":"药康生物11月06日主力资金流出1270万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481640365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481640365?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:19","pubTimestamp":1730877558,"startTime":"0","endTime":"0","summary":"11月06日, 药康生物股价跌1.57%，报收13.78元，成交金额1.03亿元，换手率3.67%，振幅3.79%，量比1.17。药康生物今日主力资金净流出1270万元，连续3日净流出，上一交易日主力净流出1360万元，今日环比减少6.62%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为56.25%，平均跌幅为1.90%。该股近5个交易日上涨0.80%，主力资金累计净流出3728万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出2659万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106153854aba5340c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106153854aba5340c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2481930965","title":"华安证券：给予药康生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481930965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481930965?lang=zh_cn&edition=full","pubTime":"2024-11-05 08:45","pubTimestamp":1730767519,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超近期对药康生物进行研究并发布了研究报告《收入稳步增长，费用投放加大等因素致利润承压》，本报告对药康生物给出买入评级，当前股价为13.35元。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级2家，增持评级4家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500007331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","688046"],"gpt_icon":0},{"id":"2481759365","title":"华安证券给予药康生物买入评级，收入稳步增长，费用投放加大等因素致利润承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2481759365","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481759365?lang=zh_cn&edition=full","pubTime":"2024-11-05 08:44","pubTimestamp":1730767490,"startTime":"0","endTime":"0","summary":"华安证券11月04日发布研报称，给予药康生物（688046.SH，最新价：13.35元）买入评级。评级理由主要包括：1）收入端稳健增长，费用投放加大等因素影响利润表现；2）海外市场积极拓展，产能利用率稳步提升。风险提示：基因编辑通用技术升级迭代风险；实验动物管理风险；新产品动物模型研发风险；市场放量不及预期风险；工业端恢复不及预期风险。AI点评：药康生物近一个月获得2份券商研报关注，买入1家。文章来源：每日经济新闻原标题：华安证券给予药康生物买入评级，收入稳步增长，费用投放加大等因素致利润承压","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105084912a2164120&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105084912a2164120&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","600909"],"gpt_icon":0},{"id":"2480583783","title":"药康生物：10月31日接受机构调研，包括知名机构聚鸣投资的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2480583783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480583783?lang=zh_cn&edition=full","pubTime":"2024-11-04 21:35","pubTimestamp":1730727326,"startTime":"0","endTime":"0","summary":"Q3 海外市场拓展顺利，新客户数量持续增长，同时在非核心区域，增加和代理商合作，提高市场渗透率。公司本年度战略入股灵康生物，将业务拓展至实验猪领域。答：公司目前库存股约 150 万股，并于近期公告了新的股份购计划，适时会推出股权激励或员工持股计划。该股最近90天内共有6家机构给出评级，买入评级2家，增持评级4家。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400031439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2480365035","title":"开源证券：给予药康生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480365035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480365035?lang=zh_cn&edition=full","pubTime":"2024-11-03 20:46","pubTimestamp":1730637982,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对药康生物进行研究并发布了研究报告《公司信息更新报告：前三季度营收稳健增长，多因素影响利润阶段性承压》，本报告对药康生物给出买入评级，当前股价为13.12元。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级2家，增持评级4家。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110300001814.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688046"],"gpt_icon":0},{"id":"2479745927","title":"药康生物(688046)9月30日股东户数0.65万户，较上期减少13.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479745927","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479745927?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:10","pubTimestamp":1730365826,"startTime":"0","endTime":"0","summary":"证券之星消息，近日药康生物披露，截至2024年9月30日公司股东户数为6479.0户，较6月30日减少1035.0户，减幅为13.77%。在医疗服务行业个股中，药康生物股东户数低于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.51万户。从股价来看，2024年6月30日至2024年9月30日，药康生物区间涨幅为46.72%，在此期间股东户数减少1035.0户，减幅为13.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100033737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2479716357","title":"药康生物大跌5.04% 5家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2479716357","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479716357?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:58","pubTimestamp":1730339910,"startTime":"0","endTime":"0","summary":"10月31日，药康生物股价大幅下跌，截至09点58分，药康生物下跌5.04%，报13.01元/股，成交3489万元，换手率1.29%，振幅3.72%。此外，数据统计显示，近半年内5家券商给予增持建议，5家券商给予买入建议。资金动向截止发稿，药康生物获得主力净流出738万元，其中超大单流出408万元，大单流出329万元。最新财报显示，今年三季报，药康生物实现营业收入5.10亿元，同比增长12.13%，净利润为9,821.44万元，同比减少16.57%，基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031095836ab87a557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031095836ab87a557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2479753906","title":"图解药康生物三季报：第三季度单季净利润同比减45.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479753906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479753906?lang=zh_cn&edition=full","pubTime":"2024-10-31 02:01","pubTimestamp":1730311318,"startTime":"0","endTime":"0","summary":"证券之星消息，药康生物2024年三季报显示，公司主营收入5.1亿元，同比上升12.13%；归母净利润9821.44万元，同比下降16.57%；扣非净利润7181.03万元，同比下降12.06%；其中2024年第三季度，公司单季度主营收入1.69亿元，同比上升6.7%；单季度归母净利润2187.67万元，同比下降45.51%；单季度扣非净利润1697.33万元，同比下降47.17%；负债率16.19%，投资收益763.88万元，财务费用-627.0万元，毛利率63.65%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100003105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-04-25","address":"江苏省南京市浦口区江北新区学府路12号","stockEarnings":[{"period":"1week","weight":-0.0393},{"period":"1month","weight":0.0311},{"period":"3month","weight":0.2567},{"period":"6month","weight":0.2604},{"period":"1year","weight":-0.2789},{"period":"ytd","weight":-0.2975}],"companyName":"江苏集萃药康生物科技股份有限公司","boardCode":"AI0073","perCapita":"31475股","boardName":"研究和试验发展","registeredCapital":"41000万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":"　　江苏集萃药康生物科技股份有限公司是一家专业从事实验动物小鼠模型的研发、生产、销售及相关技术服务的高新技术企业，主要产品有商品化小鼠模型销售业务、模型定制业务、定制繁育业务、功能药效业务、代理进出口及其他业务。公司为国内模式动物行业龙头企业之一，是亚洲小鼠突变和资源联盟唯一企业成员、国家科技资源共享服务平台（国家遗传工程小鼠资源库）共建单位，先后被认定为国家级高新技术企业、江苏省博士后创新实践基地、江苏省工程技术研究中心、国家级专精特新小巨人企业等。","serverTime":1734707080630,"listedPrice":22.53,"stockholders":"6479人(较上一季度减少13.77%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药康生物,688046,药康生物股票,药康生物股票老虎,药康生物股票老虎国际,药康生物行情,药康生物股票行情,药康生物股价,药康生物股市,药康生物股票价格,药康生物股票交易,药康生物股票购买,药康生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}